Clinical Trial 48545

Phoenix, AZ 85012


Summary:

A Phase II/III, multicentre, 8-week run-in phase followed by a 12- week, prospective, parallel-group, double-blind, randomized withdrawal, placebo-controlled study, with a 52 week open label extension, to evaluate the efficacy and safety of daily 1.5 to 3.5 mg basimglurant in patients with pain associated with trigeminal neuralgia with suboptimal response to their current anti-pain therapy.


Qualified Participants Must:

• 18-75 yr old
• need to have trigeminal neurlagia
• no bipolar, no schizophrenia, cannot me on antipsychotitcs, or mood stabilizers
• pain medication ok


Qualified Participants May Receive:

Will receive compensation for time and travel 


Available At:

Alea Research
3030 N. Central Ave.
Ste 607
Phoenix, AZ 85012
View Clinic Location

 


If you or someone you care for is interested in participating and lives within 50 miles of the location shown, please complete the form below and click 'Submit'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.